vs

Side-by-side financial comparison of Axogen, Inc. (AXGN) and HERITAGE FINANCIAL CORP (HFWA). Click either name above to swap in a different company.

HERITAGE FINANCIAL CORP is the larger business by last-quarter revenue ($66.3M vs $61.5M, roughly 1.1× Axogen, Inc.). HERITAGE FINANCIAL CORP runs the higher net margin — 33.5% vs -31.9%, a 65.4% gap on every dollar of revenue. On growth, Axogen, Inc. posted the faster year-over-year revenue change (26.6% vs 16.3%). HERITAGE FINANCIAL CORP produced more free cash flow last quarter ($85.7M vs $-1.4M). Over the past eight quarters, HERITAGE FINANCIAL CORP's revenue compounded faster (16.8% CAGR vs 13.3%).

Axogen is a developer of surgical solutions, including human tissue grafts, based in Alachua, Florida. Axogen products are designed to remedy peripheral nerve damage. In 2013 the company raised $18 million in its initial public offering (IPO). Axogen uses a cell graft technology AVANCE to mimic a human nerve. The company also creates nerve connectors and soft tissue membranes. The company reports sensory and movement recovery in 87 percent of patients with peripheral nerve injuries. Axogen is...

Heritage Financial Corp (WA) is a U.S. regional financial holding company headquartered in Washington state. It provides comprehensive commercial and consumer banking services, including deposit products, small business loans, residential mortgages, personal lending and wealth management solutions, primarily serving local communities across the Pacific Northwest, with core customer segments covering small-to-medium enterprises and retail clients.

AXGN vs HFWA — Head-to-Head

Bigger by revenue
HFWA
HFWA
1.1× larger
HFWA
$66.3M
$61.5M
AXGN
Growing faster (revenue YoY)
AXGN
AXGN
+10.3% gap
AXGN
26.6%
16.3%
HFWA
Higher net margin
HFWA
HFWA
65.4% more per $
HFWA
33.5%
-31.9%
AXGN
More free cash flow
HFWA
HFWA
$87.1M more FCF
HFWA
$85.7M
$-1.4M
AXGN
Faster 2-yr revenue CAGR
HFWA
HFWA
Annualised
HFWA
16.8%
13.3%
AXGN

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
AXGN
AXGN
HFWA
HFWA
Revenue
$61.5M
$66.3M
Net Profit
$-19.6M
$22.2M
Gross Margin
75.2%
Operating Margin
20.2%
38.7%
Net Margin
-31.9%
33.5%
Revenue YoY
26.6%
16.3%
Net Profit YoY
-410.8%
86.4%
EPS (diluted)
$-0.38
$0.65

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AXGN
AXGN
HFWA
HFWA
Q1 26
$61.5M
Q4 25
$59.9M
$66.3M
Q3 25
$60.1M
$65.7M
Q2 25
$56.7M
$56.5M
Q1 25
$48.6M
$57.6M
Q4 24
$49.4M
$57.1M
Q3 24
$48.6M
$54.8M
Q2 24
$47.9M
$56.4M
Net Profit
AXGN
AXGN
HFWA
HFWA
Q1 26
$-19.6M
Q4 25
$-13.2M
$22.2M
Q3 25
$708.0K
$19.2M
Q2 25
$579.0K
$12.2M
Q1 25
$-3.8M
$13.9M
Q4 24
$450.0K
$11.9M
Q3 24
$-1.9M
$11.4M
Q2 24
$-1.9M
$14.2M
Gross Margin
AXGN
AXGN
HFWA
HFWA
Q1 26
75.2%
Q4 25
74.1%
Q3 25
76.6%
Q2 25
74.2%
Q1 25
71.9%
Q4 24
76.1%
Q3 24
74.9%
Q2 24
73.8%
Operating Margin
AXGN
AXGN
HFWA
HFWA
Q1 26
20.2%
Q4 25
-16.3%
38.7%
Q3 25
3.2%
34.0%
Q2 25
3.0%
25.6%
Q1 25
-3.4%
28.1%
Q4 24
4.1%
28.6%
Q3 24
-0.6%
23.8%
Q2 24
-0.9%
28.4%
Net Margin
AXGN
AXGN
HFWA
HFWA
Q1 26
-31.9%
Q4 25
-22.0%
33.5%
Q3 25
1.2%
29.2%
Q2 25
1.0%
21.6%
Q1 25
-7.9%
24.2%
Q4 24
0.9%
20.9%
Q3 24
-3.8%
20.8%
Q2 24
-4.0%
25.1%
EPS (diluted)
AXGN
AXGN
HFWA
HFWA
Q1 26
$-0.38
Q4 25
$-0.28
$0.65
Q3 25
$0.01
$0.55
Q2 25
$0.01
$0.36
Q1 25
$-0.08
$0.40
Q4 24
$-0.00
$0.34
Q3 24
$-0.04
$0.33
Q2 24
$-0.04
$0.41

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AXGN
AXGN
HFWA
HFWA
Cash + ST InvestmentsLiquidity on hand
$82.7M
$233.1M
Total DebtLower is stronger
Stockholders' EquityBook value
$244.8M
$921.5M
Total Assets
$289.5M
$7.0B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AXGN
AXGN
HFWA
HFWA
Q1 26
$82.7M
Q4 25
$41.5M
$233.1M
Q3 25
$35.8M
$245.5M
Q2 25
$29.9M
$254.1M
Q1 25
$22.1M
$248.7M
Q4 24
$33.5M
$117.1M
Q3 24
$24.5M
$175.6M
Q2 24
$21.1M
$113.8M
Total Debt
AXGN
AXGN
HFWA
HFWA
Q1 26
Q4 25
$48.4M
Q3 25
$48.2M
Q2 25
$47.9M
Q1 25
$47.7M
Q4 24
$47.5M
Q3 24
$47.3M
Q2 24
$47.0M
Stockholders' Equity
AXGN
AXGN
HFWA
HFWA
Q1 26
$244.8M
Q4 25
$128.8M
$921.5M
Q3 25
$120.8M
$904.1M
Q2 25
$112.3M
$888.2M
Q1 25
$105.4M
$881.5M
Q4 24
$103.9M
$863.5M
Q3 24
$99.4M
$874.5M
Q2 24
$95.7M
$850.5M
Total Assets
AXGN
AXGN
HFWA
HFWA
Q1 26
$289.5M
Q4 25
$221.7M
$7.0B
Q3 25
$216.4M
$7.0B
Q2 25
$205.5M
$7.1B
Q1 25
$196.2M
$7.1B
Q4 24
$203.7M
$7.1B
Q3 24
$192.0M
$7.2B
Q2 24
$188.9M
$7.1B
Debt / Equity
AXGN
AXGN
HFWA
HFWA
Q1 26
Q4 25
0.38×
Q3 25
0.40×
Q2 25
0.43×
Q1 25
0.45×
Q4 24
0.46×
Q3 24
0.48×
Q2 24
0.49×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AXGN
AXGN
HFWA
HFWA
Operating Cash FlowLast quarter
$94.8M
Free Cash FlowOCF − Capex
$-1.4M
$85.7M
FCF MarginFCF / Revenue
-2.3%
129.1%
Capex IntensityCapex / Revenue
13.8%
Cash ConversionOCF / Net Profit
4.26×
TTM Free Cash FlowTrailing 4 quarters
$9.1M
$149.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AXGN
AXGN
HFWA
HFWA
Q1 26
Q4 25
$3.0M
$94.8M
Q3 25
$3.2M
$25.1M
Q2 25
$7.7M
$22.5M
Q1 25
$-13.2M
$19.3M
Q4 24
$8.7M
$64.5M
Q3 24
$3.9M
$24.2M
Q2 24
$4.2M
$6.8M
Free Cash Flow
AXGN
AXGN
HFWA
HFWA
Q1 26
$-1.4M
Q4 25
$1.8M
$85.7M
Q3 25
$1.7M
$24.4M
Q2 25
$7.0M
$20.9M
Q1 25
$-13.4M
$18.1M
Q4 24
$8.1M
$61.0M
Q3 24
$3.3M
$23.2M
Q2 24
$3.3M
$6.0M
FCF Margin
AXGN
AXGN
HFWA
HFWA
Q1 26
-2.3%
Q4 25
3.0%
129.1%
Q3 25
2.8%
37.1%
Q2 25
12.4%
37.0%
Q1 25
-27.7%
31.4%
Q4 24
16.3%
107.0%
Q3 24
6.8%
42.4%
Q2 24
6.8%
10.6%
Capex Intensity
AXGN
AXGN
HFWA
HFWA
Q1 26
Q4 25
2.1%
13.8%
Q3 25
2.5%
1.0%
Q2 25
1.3%
2.8%
Q1 25
0.5%
2.0%
Q4 24
1.4%
6.1%
Q3 24
1.2%
1.7%
Q2 24
1.9%
1.5%
Cash Conversion
AXGN
AXGN
HFWA
HFWA
Q1 26
Q4 25
4.26×
Q3 25
4.55×
1.31×
Q2 25
13.35×
1.84×
Q1 25
1.38×
Q4 24
19.41×
5.41×
Q3 24
2.12×
Q2 24
0.48×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons